BioDlink International clarifies director and executive changes
BioDlink International Company Limited (Stock Code: 1875) announced on October 16, 2025, a supplemental update regarding changes to its board and executive management. This follows an earlier announcement dated October 13, 2025.
The company clarified that Dr. Liu resigned as an executive director, chief executive officer, chief scientific officer, and a member of the Strategy and ESG Committee due to personal reasons. Additionally, Ms. Yeh-Huang resigned as a non-executive director, vice chairperson of the board, and a member of the Strategy and ESG Committee, also for personal reasons. The company specified that both resignations were due to "his/her family reasons."
As of the announcement date, the executive director of the company is Mr. Fu, Shan. The non-executive director is Dr. Liu, Weidong, while independent non-executive directors include Ms. Sun, Hui, Mr. Zhang, Qing, and Dr. Gu, Xuelin. All other information from the initial announcement remains unchanged.
This report was generated by FilingReader's AI system from regulatory filings and company disclosures. To request a correction, contact editorial@filingreader.com
News Alerts
Get instant email alerts when TOT BIOPHARM International publishes news
Free account required • Unsubscribe anytime